Covert DATIX Chief MMC Any inappropriate Directorates administration Pharmacist actions to be reviewed of medicines with Directorates (Rare) Equality Impact Assessment Tool Appendix 1 – Yes/No Comments 1 Does the policy/guidance affect one group less or more favourably than another on the basis of: Race No Disability No Gender No Religion or belief No Sexual orientation including lesbian, gay No and bisexual people Age No 2 Is there any evidence that some groups are No affected differently? 3 If you have identified potential discrimination, are No any exceptions valid, legal and/or justifiable? 4 Is the impact of the policy/guidance likely to be No negative? 5 If so can the impact be avoided? 6 What alternatives are there to achieving the policy/guidance without the impact? 7 Can we reduce the impact by taking different action?
Covert administration of medicines (Rare) DATIX Chief Pharmacist MMC Any inappropriate actions to be reviewed with Directorates Directorates Equality Impact Assessment Tool – Appendix 1 Yes/No Comments 1 Does the policy/guidance affect one group less or more favourably than another on the basis of: Race No Disability No Gender No Religion or belief No Sexual orientation including lesbian, gay and bisexual people No Age No 2 Is there any evidence that some groups are affected differently? No 3 If you have identified potential discrimination, are any exceptions valid, legal and/or justifiable? No 4 Is the impact of the policy/guidance likely to be negative? No 5 If so can the impact be avoided? 6 What alternatives are there to achieving the policy/guidance without the impact? 7 Can we reduce the impact by taking different action?
CORPORATE%20POLICY%20-%20Medicines%20Management%20Policy%20-%20POLCPCM033-6.docx